3258 articles in this topic
New research finds eating grapes daily for two weeks alters skin gene expression, boosting UV protection and cutting oxidative stress markers.
Repair Biotechnologies' REP-0004 uses mRNA-lipid nanoparticles to clear toxic free cholesterol from the liver, reversing plaque and liver disease.
Fractyl Health's RJVA-001 aims to trigger lasting GLP-1 production from a single dose, as oral and multi-action obesity drugs also advance rapidly.
Cambridge-backed PREMAZ measures memory precision to catch Alzheimer's warning signs far earlier than standard cognitive tests.
A targeted RNA interference therapy slashed liver fat nearly in half in 12 weeks for patients with a common genetic variant tied to fatty liver disease.
A new health tech partnership merges diabetes management with cardiovascular monitoring to tackle cardiometabolic risk before complications arise.
Cerevance's solengepras targets GPR6 receptors to cut OFF periods in Parkinson's — a first non-dopaminergic approach in decades.
Cyclarity's UDP-003 shows first human evidence of excreting oxidized cholesterol, pointing toward reversing arterial damage rather than just slowing it.
Dr Valter Longo argues the 5-day fasting-mimicking diet triggers deep cellular repair — from autophagy peaks to tissue regeneration after refeeding.
The submitted press release could not be verified as a recent NIH publication. Content could not be summarized.
WashU Medicine's Long Life Family Study renewal uses long-read sequencing to decode why some families consistently escape age-related disease.
WashU Medicine's Long Life Family Study gets a major boost, using long-read sequencing to find why some families live exceptionally long lives.
